BackgroundPhysical activity has shown a positive impact on aging and neurodegeneration and represents a possible treatment option in cognitive decline. However, its underlying mechanisms and influences on brain pathology remain unclear. Dementia‐MOVE (Multi‐Objective Validation of Exercise) is a randomized‐controlled pilot trial, including 50 patients with amnestic cognitive impairment associated with Alzheimer's pathology, aiming to analyze the effect of physical activity and fitness on disease progression.MethodsDementia‐MOVE is divided into two arms, of either an intervention comprising physical activity, for at least twice a week, combined with a psychoeducational program, or a sole psychoeducational program. Physical activity intervent...
BACKGROUND:There is increasing interest in the role of physical exercise as a therapeutic strategy f...
Physical Activity (PA) and Cognitive Activity (CA) are generally considered protective for Alzheimer...
Alzheimer’s disease affects 5.4 million people in the United States and without a current treatment ...
Current treatment in late-life cognitive impairment and dementia is still limited, and there is no c...
Despite strong evidence from animal models of Alzheimer's disease (AD) supporting aerobic exercise a...
This abstract will provide a brief overview of the following literature review. Alzheimer’s disease ...
The Effects of Exercise on Brain Function in Alzheimer’s Patients An Integrative Literature Review ...
BackgroundOur goal was to investigate the role of physical exercise to protect brain health as we ag...
AbstractAlzheimer's disease (AD) is the most common form of dementia in elderly with major symptoms ...
Aims: To assess the potential multi-domain benefits of exercise interventions on patients with Alzhe...
Alzheimer disease (AD) is a primary cause of cognitive dysfunction in the elderly population worldwi...
BackgroundOur goal was to investigate the role of physical exercise to protect brain health as we ag...
Background: Exercise interventions to prevent dementia and delay cognitive decline have gained consi...
Background: Observational studies have documented a potential protective effect of physical exercise...
BACKGROUND: Exercise interventions to prevent dementia and delay cognitive decline have gained consi...
BACKGROUND:There is increasing interest in the role of physical exercise as a therapeutic strategy f...
Physical Activity (PA) and Cognitive Activity (CA) are generally considered protective for Alzheimer...
Alzheimer’s disease affects 5.4 million people in the United States and without a current treatment ...
Current treatment in late-life cognitive impairment and dementia is still limited, and there is no c...
Despite strong evidence from animal models of Alzheimer's disease (AD) supporting aerobic exercise a...
This abstract will provide a brief overview of the following literature review. Alzheimer’s disease ...
The Effects of Exercise on Brain Function in Alzheimer’s Patients An Integrative Literature Review ...
BackgroundOur goal was to investigate the role of physical exercise to protect brain health as we ag...
AbstractAlzheimer's disease (AD) is the most common form of dementia in elderly with major symptoms ...
Aims: To assess the potential multi-domain benefits of exercise interventions on patients with Alzhe...
Alzheimer disease (AD) is a primary cause of cognitive dysfunction in the elderly population worldwi...
BackgroundOur goal was to investigate the role of physical exercise to protect brain health as we ag...
Background: Exercise interventions to prevent dementia and delay cognitive decline have gained consi...
Background: Observational studies have documented a potential protective effect of physical exercise...
BACKGROUND: Exercise interventions to prevent dementia and delay cognitive decline have gained consi...
BACKGROUND:There is increasing interest in the role of physical exercise as a therapeutic strategy f...
Physical Activity (PA) and Cognitive Activity (CA) are generally considered protective for Alzheimer...
Alzheimer’s disease affects 5.4 million people in the United States and without a current treatment ...